RS
Ruby Siada
Credentials: ·
History
2023–2026- 2019–2023
Medical School
Research
Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma
Journal of Clinical Investigation · 2020 · 64 citations
Cell Reports · 2022 · 59 citations
STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma
Neuro-Oncology · 2022 · 28 citations

4 papers · 1 as a resident
- CK
4 papers

4 papers

4 papers

4 papers · 4 as a resident
- JC
3 papers

3 papers

3 papers · 2 as a resident


